Skip to main content

Compound 506 (2-amino-6-methoxypurine arabinoside) is active against resistant T-cell malignancies: Preliminary results of a Phase I trial prior to definition of a MTD.

Publication ,  Journal Article
Kurtzberg, J; Wiley, J; Reese, M; Elion, G; Mitchell, B
Published in: BLOOD
November 15, 1995

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 15, 1995

Volume

86

Issue

10

Start / End Page

2034 / 2034

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 15, 1995

Volume

86

Issue

10

Start / End Page

2034 / 2034

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology